No direct pharmacokinetic interactions exist between creatine and semaglutide, tirzepatide, or other GLP-1 agonists based on current clinical evidence
The needles used for GLP-1 injections are designed specifically for subcutaneous delivery and are remarkably small: 30-gauge or 31-gauge, 5/16 inch long
In Novemeber 2001 a friend of mine told me about Day Spring
This type 2 diabetes population had the following characteristics: Mean age was 60 years, 46.7% were male, 91.7% were Caucasian, 5.2% were Black or African American and 17.9% were Hispanic
The risk here isnt really the medications themselves when properly prescribed, its sourcing them from unregulated suppliers
Stacking these agents would likely intensify nausea, vomiting, constipation, and dehydration without meaningfully accelerating weight loss beyond what either drug achieves alone